The Erlangen Fitness and Prevention Study (EFOPS).

计划入组 50 人 · 首次发布于 2010 年 8 月 9 日

The Erlanger Stroke Project is an Ongoing Prospective Population-based Stroke Registry in Germany, Including All Hospitalized and Nonhospitalized Patients With Stroke in the City of Erlangen (120.000 Inhabitants).

计划入组 17,000 人 · 首次发布于 2026 年 8 月 18 日

Effect of Mulligan on Cervical Radiculopathy

计划入组 40 人 · 首次发布于 2024 年 10 月 22 日

T cell therapy(University Of Erlangen-Nuremberg Medical School)

CD19 CAR T-Cell Therapy(University Hospital Erlangen)

N-substituted amino-benzamides (Auburn University/University of Alabama)

University Hospital Erlangen

Germany

Universitätsklinikum Erlangen

Germany

Friedrich-Alexander-Universität Erlangen-Nürnberg

Germany

CAR-T Therapy Shows Promise in Refractory Autoimmune Diseases

CAR T-Cell Therapy Achieves Long-Term Remission in Autoimmune Diseases Through Complete B-Cell Depletion

Simris Biologics Appoints ADC Expert Professor Andreas Pahl as CEO to Advance Microcystin Payload Platform